{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:31:58Z","timestamp":1793046718214,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijcard.2015.03.423","type":"journal-article","created":{"date-parts":[[2015,4,6]],"date-time":"2015-04-06T06:05:42Z","timestamp":1428300342000},"page":"585-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Molecular pathogenesis of Marfan syndrome"],"prefix":"10.1016","volume":"187","author":[{"given":"Chrishan J.A.","family":"Ramachandra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Wei Qiang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Le","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Shim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2015.03.423_bb0005","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/352337a0","article-title":"Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene","volume":"352","author":"Dietz","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0010","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMe068122","article-title":"Marfan's syndrome and related disorders\u2014more tightly connected than we thought","volume":"355","author":"Gelb","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0015","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(05)67789-6","article-title":"Marfan's syndrome","volume":"366","author":"Judge","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0020","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1161\/CIRCULATIONAHA.107.693523","article-title":"Medical management of Marfan syndrome","volume":"117","author":"Keane","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0025","first-page":"888","article-title":"Diagnosis and management of infantile Marfan syndrome","volume":"86","author":"Morse","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0030","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/0002-9149(90)90979-B","article-title":"Two-dimensional and Doppler echocardiographic and pathologic characteristics of the infantile Marfan syndrome","volume":"65","author":"Geva","year":"1990","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0035","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1136\/heartjnl-2013-304709","article-title":"Diagnosis and treatment of Marfan syndrome: an update","volume":"100","author":"Radke","year":"2014","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0040","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1083\/jcb.103.6.2499","article-title":"Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils","volume":"103","author":"Sakai","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0045","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng1116","article-title":"Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome","volume":"33","author":"Neptune","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0050","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrcardio.2010.31","article-title":"Marfan syndrome. Part 2: treatment and management of patients","volume":"7","author":"Canadas","year":"2010","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0055","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1136\/jmg.2009.072785","article-title":"The revised Ghent nosology for the Marfan syndrome","volume":"47","author":"Loeys","year":"2010","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0060","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1469-1809.2009.00545.x","article-title":"Mutation spectrum of the fibrillin-1 (FBN1) gene in Taiwanese patients with Marfan syndrome","volume":"73","author":"Hung","year":"2009","journal-title":"Ann. Hum. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0065","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1253\/circj.CJ-13-0584","article-title":"Clinical features differ substantially between Caucasian and Asian populations of Marfan syndrome","volume":"77","author":"Franken","year":"2013","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0070","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/ng1097-218","article-title":"Targeting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome","volume":"17","author":"Pereira","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0075","doi-asserted-by":"crossref","first-page":"3819","DOI":"10.1073\/pnas.96.7.3819","article-title":"Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1","volume":"96","author":"Pereira","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0080","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1172\/JCI117737","article-title":"Expression of a mutant human fibrillin allele upon a normal human or murine genetic background recapitulates a Marfan cellular phenotype","volume":"95","author":"Eldadah","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0085","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1172\/JCI200420641","article-title":"Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome","volume":"114","author":"Judge","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0090","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1093\/hmg\/ddg081","article-title":"Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders","volume":"12","author":"Whiteman","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0095","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1006\/geno.1993.1349","article-title":"Four novel FBN1 mutations: significance for mutant transcript level and EGF-like domain calcium binding in the pathogenesis of Marfan syndrome","volume":"17","author":"Dietz","year":"1993","journal-title":"Genomics"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0100","doi-asserted-by":"crossref","first-page":"24943","DOI":"10.1074\/jbc.M110.130021","article-title":"In vivo studies of mutant fibrillin-1 microfibrils","volume":"285","author":"Charbonneau","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0105","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/humu.9377","article-title":"Identification of sixty-two novel and twelve known FBN1 mutations in eighty-one unrelated probands with Marfan syndrome and other fibrillinopathies","volume":"26","author":"Arbustini","year":"2005","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0110","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1086\/520125","article-title":"Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study","volume":"81","author":"Faivre","year":"2007","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0115","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/eurheartj\/ehq258","article-title":"Cardiovascular manifestations in men and women carrying a FBN1 mutation","volume":"31","author":"Detaint","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0120","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1034\/j.1399-0004.1999.550207.x","article-title":"Novel exon skipping mutation in the fibrillin-1 gene: two \u2018hot spots\u2019 for the neonatal Marfan syndrome","volume":"55","author":"Booms","year":"1999","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00431-003-1330-8","article-title":"Congenital diaphragmatic eventration and bilateral uretero-hydronephrosis in a patient with neonatal Marfan syndrome caused by a mutation in exon 25 of the FBN1 gene and review of the literature","volume":"163","author":"Revencu","year":"2004","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0130","doi-asserted-by":"crossref","first-page":"e81281","DOI":"10.1371\/journal.pone.0081281","article-title":"Observational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations","volume":"8","author":"Aydin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0135","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejmg.2009.11.001","article-title":"Paucity of skeletal manifestations in Hispanic families with FBN1 mutations","volume":"53","author":"Villamizar","year":"2010","journal-title":"Eur. J. Med. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0140","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/j.1399-0004.2009.01287.x","article-title":"Clinical and genetic analysis of Korean patients with Marfan syndrome: possible ethnic differences in clinical manifestation","volume":"77","author":"Yoo","year":"2010","journal-title":"Clin. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0145","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00439-007-0371-x","article-title":"Large genomic fibrillin-1 (FBN1) gene deletions provide evidence for true haploinsufficiency in Marfan syndrome","volume":"122","author":"Matyas","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0150","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/humu.21525","article-title":"Applying massive parallel sequencing to molecular diagnosis of Marfan and Loeys\u2013Dietz syndromes","volume":"32","author":"Baetens","year":"2011","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/humu.22540","article-title":"An FBN1 deep intronic mutation in a familial case of Marfan syndrome: an explanation for genetically unsolved cases?","volume":"35","author":"Gillis","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0160","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2156-15-74","article-title":"New population-based exome data question the pathogenicity of some genetic variants previously associated with Marfan syndrome","volume":"15","author":"Yang","year":"2014","journal-title":"BMC Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0165","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1172\/JCI200422715","article-title":"TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome","volume":"114","author":"Ng","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1126\/science.1124287","article-title":"Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome","volume":"312","author":"Habashi","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0175","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.ijcard.2013.03.033","article-title":"Circulating transforming growth factor-beta as a prognostic biomarker in Marfan syndrome","volume":"168","author":"Franken","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0180","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.108.841981","article-title":"Circulating transforming growth factor-beta in Marfan syndrome","volume":"120","author":"Matt","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0185","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.1192149","article-title":"Noncanonical TGFbeta signaling contributes to aortic aneurysm progression in Marfan syndrome mice","volume":"332","author":"Holm","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0190","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1172\/JCI69942","article-title":"Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis","volume":"124","author":"Li","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0195","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/cvr\/cvq291","article-title":"Epigenetic control of vascular smooth muscle cells in Marfan and non-Marfan thoracic aortic aneurysms","volume":"89","author":"Gomez","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0200","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCRESAHA.113.301989","article-title":"Modifications of chromatin dynamics control Smad2 pathway activation in aneurysmal smooth muscle cells","volume":"113","author":"Gomez","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0205","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/ng.2421","article-title":"Mutations in the TGF-beta repressor SKI cause Shprintzen\u2013Goldberg syndrome with aortic aneurysm","volume":"44","author":"Doyle","year":"2012","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0210","first-page":"II331","article-title":"Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome","volume":"98","author":"Segura","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0215","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1161\/CIRCRESAHA.107.157776","article-title":"Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome","volume":"101","author":"Chung","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0220","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/01.RES.88.1.37","article-title":"Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome","volume":"88","author":"Bunton","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0225","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1161\/CIRCRESAHA.108.174367","article-title":"Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in Marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9","volume":"102","author":"Chung","year":"2008","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0230","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1161\/CIRCRESAHA.112.268268","article-title":"MMP-2 regulates Erk1\/2 phosphorylation and aortic dilatation in Marfan syndrome","volume":"110","author":"Xiong","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0235","doi-asserted-by":"crossref","first-page":"I365","DOI":"10.1161\/CIRCULATIONAHA.105.000810","article-title":"Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with Marfan syndrome","volume":"114","author":"Ikonomidis","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0240","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2013.11.044","article-title":"Aortic biomechanics by magnetic resonance: early markers of aortic disease in Marfan syndrome regardless of aortic dilatation?","volume":"171","author":"Teixido-Tura","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0245","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1073\/pnas.0910312107","article-title":"Distinct defects in collagen microarchitecture underlie vessel-wall failure in advanced abdominal aneurysms and aneurysms in Marfan syndrome","volume":"107","author":"Lindeman","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0250","first-page":"1329","article-title":"Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome","volume":"124","author":"Cook","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0255","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1161\/01.CIR.99.21.2750","article-title":"Dilated cardiomyopathy is associated with significant changes in collagen type I\/III ratio","volume":"99","author":"Pauschinger","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0260","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1161\/01.CIR.97.17.1708","article-title":"Increased matrix metalloproteinase activity and selective upregulation in LV myocardium from patients with end-stage dilated cardiomyopathy","volume":"97","author":"Thomas","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0265","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1388-9842(99)00048-3","article-title":"Altered balance between matrix gelatinases (MMP-2 and MMP-9) and their tissue inhibitors in human dilated cardiomyopathy: potential role of MMP-9 in myosin-heavy chain degradation","volume":"1","author":"Rouet-Benzineb","year":"1999","journal-title":"Eur. J. Heart Fail."},{"issue":"Suppl. 1","key":"10.1016\/j.ijcard.2015.03.423_bb0270","first-page":"II329","article-title":"Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in Marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm","volume":"108","author":"Nataatmadja","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0275","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1007\/s00018-011-0780-9","article-title":"Genetic and functional linkage between ADAMTS superfamily proteins and fibrillin-1: a novel mechanism influencing microfibril assembly and function","volume":"68","author":"Hubmacher","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0280","doi-asserted-by":"crossref","first-page":"38602","DOI":"10.1074\/jbc.M111.243451","article-title":"ADAMTSL6beta protein rescues fibrillin-1 microfibril disorder in a Marfan syndrome mouse model through the promotion of fibrillin-1 assembly","volume":"286","author":"Saito","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0285","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1161\/CIRCRESAHA.111.253740","article-title":"miR-29b participates in early aneurysm development in Marfan syndrome","volume":"110","author":"Merk","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0290","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1161\/CIRCRESAHA.111.255737","article-title":"MicroRNA-29 in aortic dilation: implications for aneurysm formation","volume":"109","author":"Boon","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0295","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s004390000368","article-title":"Differential effect of FBN1 mutations on in vitro proteolysis of recombinant fibrillin-1 fragments","volume":"107","author":"Booms","year":"2000","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0300","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1161\/CIRCRESAHA.113.301498","article-title":"Thoracic aortic aneurysm frequency and dissection are associated with fibrillin-1 fragment concentrations in circulation","volume":"113","author":"Marshall","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0305","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00439-004-1194-7","article-title":"RGD-containing fibrillin-1 fragments upregulate matrix metalloproteinase expression in cell culture: a potential factor in the pathogenesis of the Marfan syndrome","volume":"116","author":"Booms","year":"2005","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0310","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.yjmcc.2005.11.009","article-title":"A fibrillin-1-fragment containing the elastin-binding-protein GxxPG consensus sequence upregulates matrix metalloproteinase-1: biochemical and computational analysis","volume":"40","author":"Booms","year":"2006","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0315","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1161\/CIRCULATIONAHA.105.601674","article-title":"Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a GxxPG-containing fibrillin-1 fragment","volume":"114","author":"Guo","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0320","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/hmg\/dds439","article-title":"Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice","volume":"22","author":"Guo","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0325","doi-asserted-by":"crossref","first-page":"e32963","DOI":"10.1371\/journal.pone.0032963","article-title":"Inflammation aggravates disease severity in Marfan syndrome patients","volume":"7","author":"Radonic","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0330","doi-asserted-by":"crossref","first-page":"e000476","DOI":"10.1161\/JAHA.113.000476","article-title":"IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR\/mgR mouse model of severe Marfan syndrome","volume":"3","author":"Ju","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0335","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.vph.2009.10.005","article-title":"Vasomotor dysfunction in the thoracic aorta of Marfan syndrome is associated with accumulation of oxidative stress","volume":"52","author":"Yang","year":"2010","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0340","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.110.990549","article-title":"Increased vertebral artery tortuosity index is associated with adverse outcomes in children and young adults with connective tissue disorders","volume":"124","author":"Morris","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0345","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1056\/NEJMoa0706585","article-title":"Angiotensin II blockade and aortic-root dilation in Marfan's syndrome","volume":"358","author":"Brooke","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0350","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1093\/eurheartj\/eht334","article-title":"Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial","volume":"34","author":"Groenink","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0355","doi-asserted-by":"crossref","first-page":"354","DOI":"10.2459\/JCM.0b013e3283232a45","article-title":"Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations","volume":"10","author":"Gambarin","year":"2009","journal-title":"J. Cardiovasc. Med."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0360","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.recesp.2011.02.009","article-title":"Study of the efficacy and safety of losartan versus atenolol for aortic dilation in patients with Marfan syndrome","volume":"64","author":"Forteza","year":"2011","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0365","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijcard.2010.12.070","article-title":"The Ghent Marfan Trial\u2014a randomized, double-blind placebo controlled trial with losartan in Marfan patients treated with beta-blockers","volume":"157","author":"Moberg","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0370","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1186\/1745-6215-14-408","article-title":"A prospective, randomized, placebo-controlled, double-blind, multicenter study of the effects of irbesartan on aortic dilatation in Marfan syndrome (AIMS trial): study protocol","volume":"14","author":"Mullen","year":"2013","journal-title":"Trials"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0375","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.ahj.2013.02.019","article-title":"Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy","volume":"165","author":"Lacro","year":"2013","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0380","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/clc.22320","article-title":"Total serum transforming growth factor-beta1 is elevated in the entire spectrum of genetic aortic syndromes","volume":"37","author":"Hillebrand","year":"2014","journal-title":"Clin. Cardiol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0385","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0390","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/cvr\/cvr132","article-title":"Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells","volume":"91","author":"Mehta","year":"2011","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0395","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/cvr\/cvu060","article-title":"Re-trafficking of hERG reverses long QT syndrome 2 phenotype in human iPS-derived cardiomyocytes","volume":"102","author":"Mehta","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0400","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/CIRCRESAHA.112.268623","article-title":"Induced pluripotent stem cell-derived cardiomyocytes: a versatile tool for arrhythmia research","volume":"112","author":"Sinnecker","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0405","doi-asserted-by":"crossref","first-page":"130ra47","DOI":"10.1126\/scitranslmed.3003552","article-title":"Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy","volume":"4","author":"Sun","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0410","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature09879","article-title":"Recapitulation of premature ageing with iPSCs from Hutchinson\u2013Gilford progeria syndrome","volume":"472","author":"Liu","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0415","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.stem.2010.12.002","article-title":"A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects","volume":"8","author":"Zhang","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0420","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1161\/CIRCULATIONAHA.112.116996","article-title":"Modeling supravalvular aortic stenosis syndrome with human induced pluripotent stem cells","volume":"126","author":"Ge","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0425","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1073\/pnas.1113442109","article-title":"Skeletogenic phenotype of human Marfan embryonic stem cells faithfully phenocopied by patient-specific induced-pluripotent stem cells","volume":"109","author":"Quarto","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0430","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1002\/stem.1250","article-title":"Exogenous activation of BMP-2 signaling overcomes TGFbeta-mediated inhibition of osteogenesis in Marfan embryonic stem cells and Marfan patient-specific induced pluripotent stem cells","volume":"30","author":"Quarto","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijcard.2015.03.423_bb0435","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGENETICS.114.000950","article-title":"Beneficial outcome of losartan therapy depends on type of FBN1 mutation in Marfan syndrome","author":"Franken","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0440","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/sj.bjp.0707181","article-title":"Endothelial dysfunction and compromised eNOS\/Akt signaling in the thoracic aorta during the progression of Marfan syndrome","volume":"150","author":"Chung","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijcard.2015.03.423_bb0445","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1136\/heartjnl-2011-300169","article-title":"Intrinsic biventricular dysfunction in Marfan syndrome","volume":"97","author":"de Witte","year":"2011","journal-title":"Heart"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315006865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315006865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T00:26:43Z","timestamp":1566520003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315006865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":89,"alternative-id":["S0167527315006865"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.423","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular pathogenesis of Marfan syndrome","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.423","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ireland Ltd.","name":"copyright","label":"Copyright"}]}}